US$ 21.64
glp-1 gip lilly GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica New GLP-1 Pill Foundayo (Orforglipron)
Description
Depending on your IBS subtype and symptoms, GLP-1s may either improve or aggravate gastrointestinal symptoms such as bloating, constipation, urgency or abdominal pain

Epidemiological data confirms this overlap
They may also reduce the risk of heart disease, kidney issues, and sleep apnea

Additionally, liraglutide and semaglutide are approved to reduce CVD risk in patients with CVD and T2DM

& Brubaker, M
